Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2018-08-17

Clinical Trial Update: The Renin-Aldosterone Axis in Postural Tachycardia Syndrome [Phase 1]

View source ↗

Summary

Phase 1 trial investigating the renin-aldosterone axis in Postural Orthostatic Tachycardia Syndrome; results have been posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Vanderbilt University Medical Center | Conditions: Postural Orthostatic Tachycardia Syndrome (POTS) | Phase 1 | Status: COMPLETED | Results posted: 2018-08-17